Alliance acquires Biogix and its Amberen brand

30 December 2020 - Deborah Wilkes

Premium

Alliance Pharma has strengthened its consumer healthcare presence in the US by acquiring Biogix, including its Amberen brand, for USD110 million in cash.

Click tags below for more information on topics:

Alliance Pharma

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: